The global market for Long-Acting Cholesterol-Lowering Drugs was valued at US$ 1674 million in the year 2024 and is projected to reach a revised size of US$ 2316 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Long-Acting Cholesterol-Lowering Drugs Market

Long-acting cholesterol-lowering drugs are a class of medications that can continuously reduce cholesterol levels in the blood. These drugs typically inhibit the synthesis or absorption of cholesterol, reducing its accumulation in the body. The hallmark of long-acting cholesterol-lowering drugs is their long half-life and sustained efficacy, allowing patients to maintain stable cholesterol levels with fewer doses. These drugs play a crucial role in treating hypercholesterolemia and preventing cardiovascular diseases. Common long-acting cholesterol-lowering drugs include statins and certain novel agents, such as pcsk9 inhibitors. By continuously lowering cholesterol levels, these drugs help reduce the risk of cardiovascular diseases and improve patients' quality.

North American market for Long-Acting Cholesterol-Lowering Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Long-Acting Cholesterol-Lowering Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Long-Acting Cholesterol-Lowering Drugs in Hyperlipidemia is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Long-Acting Cholesterol-Lowering Drugs include LEQVIO (Novartis), Verve Therapeutics, Jiangsu Hengrui Pharmaceuticals, Amgen, Sanofi, Innovent, Akesobio, Junshi Biosciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Long-Acting Cholesterol-Lowering Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Cholesterol-Lowering Drugs.

The Long-Acting Cholesterol-Lowering Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-Acting Cholesterol-Lowering Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Long-Acting Cholesterol-Lowering Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Long-Acting Cholesterol-Lowering Drugs Market Report

Report Metric	Details
Report Name	Long-Acting Cholesterol-Lowering Drugs Market
Accounted market size in year	US$ 1674 million
Forecasted market size in 2031	US$ 2316 million
CAGR	5.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Long-Acting Cholesterol-Lowering Drugs Ultra-Long-Acting Cholesterol-Lowering Drugs
Segment by Application	Hyperlipidemia Hypertension Diabetes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	LEQVIO (Novartis), Verve Therapeutics, Jiangsu Hengrui Pharmaceuticals, Amgen, Sanofi, Innovent, Akesobio, Junshi Biosciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-Acting Cholesterol-Lowering Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Long-Acting Cholesterol-Lowering Drugs Market growing?

Ans: The Long-Acting Cholesterol-Lowering Drugs Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Long-Acting Cholesterol-Lowering Drugs Market size in 2031?

Ans: The Long-Acting Cholesterol-Lowering Drugs Market size in 2031 will be US$ 2316 million.

Who are the main players in the Long-Acting Cholesterol-Lowering Drugs Market report?

Ans: The main players in the Long-Acting Cholesterol-Lowering Drugs Market are LEQVIO (Novartis), Verve Therapeutics, Jiangsu Hengrui Pharmaceuticals, Amgen, Sanofi, Innovent, Akesobio, Junshi Biosciences

What are the Application segmentation covered in the Long-Acting Cholesterol-Lowering Drugs Market report?

Ans: The Applications covered in the Long-Acting Cholesterol-Lowering Drugs Market report are Hyperlipidemia, Hypertension, Diabetes, Others

What are the Type segmentation covered in the Long-Acting Cholesterol-Lowering Drugs Market report?

Ans: The Types covered in the Long-Acting Cholesterol-Lowering Drugs Market report are Long-Acting Cholesterol-Lowering Drugs, Ultra-Long-Acting Cholesterol-Lowering Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Long-Acting Cholesterol-Lowering Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Long-Acting Cholesterol-Lowering Drugs

1.2.3 Ultra-Long-Acting Cholesterol-Lowering Drugs

1.3 Market by Application

1.3.1 Global Long-Acting Cholesterol-Lowering Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hyperlipidemia

1.3.3 Hypertension

1.3.4 Diabetes

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Long-Acting Cholesterol-Lowering Drugs Market Perspective (2020-2031)

2.2 Global Long-Acting Cholesterol-Lowering Drugs Growth Trends by Region

2.2.1 Global Long-Acting Cholesterol-Lowering Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Long-Acting Cholesterol-Lowering Drugs Historic Market Size by Region (2020-2025)

2.2.3 Long-Acting Cholesterol-Lowering Drugs Forecasted Market Size by Region (2026-2031)

2.3 Long-Acting Cholesterol-Lowering Drugs Market Dynamics

2.3.1 Long-Acting Cholesterol-Lowering Drugs Industry Trends

2.3.2 Long-Acting Cholesterol-Lowering Drugs Market Drivers

2.3.3 Long-Acting Cholesterol-Lowering Drugs Market Challenges

2.3.4 Long-Acting Cholesterol-Lowering Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Long-Acting Cholesterol-Lowering Drugs Players by Revenue

3.1.1 Global Top Long-Acting Cholesterol-Lowering Drugs Players by Revenue (2020-2025)

3.1.2 Global Long-Acting Cholesterol-Lowering Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Top Long-Acting Cholesterol-Lowering Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Long-Acting Cholesterol-Lowering Drugs Revenue

3.4 Global Long-Acting Cholesterol-Lowering Drugs Market Concentration Ratio

3.4.1 Global Long-Acting Cholesterol-Lowering Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Cholesterol-Lowering Drugs Revenue in 2024

3.5 Global Key Players of Long-Acting Cholesterol-Lowering Drugs Head office and Area Served

3.6 Global Key Players of Long-Acting Cholesterol-Lowering Drugs, Product and Application

3.7 Global Key Players of Long-Acting Cholesterol-Lowering Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Long-Acting Cholesterol-Lowering Drugs Breakdown Data by Type

4.1 Global Long-Acting Cholesterol-Lowering Drugs Historic Market Size by Type (2020-2025)

4.2 Global Long-Acting Cholesterol-Lowering Drugs Forecasted Market Size by Type (2026-2031)

5 Long-Acting Cholesterol-Lowering Drugs Breakdown Data by Application

5.1 Global Long-Acting Cholesterol-Lowering Drugs Historic Market Size by Application (2020-2025)

5.2 Global Long-Acting Cholesterol-Lowering Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Long-Acting Cholesterol-Lowering Drugs Market Size (2020-2031)

6.2 North America Long-Acting Cholesterol-Lowering Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2020-2025)

6.4 North America Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Long-Acting Cholesterol-Lowering Drugs Market Size (2020-2031)

7.2 Europe Long-Acting Cholesterol-Lowering Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2020-2025)

7.4 Europe Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Size (2020-2031)

8.2 Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Long-Acting Cholesterol-Lowering Drugs Market Size (2020-2031)

9.2 Latin America Long-Acting Cholesterol-Lowering Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2020-2025)

9.4 Latin America Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Size (2020-2031)

10.2 Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 LEQVIO (Novartis)

11.1.1 LEQVIO (Novartis) Company Details

11.1.2 LEQVIO (Novartis) Business Overview

11.1.3 LEQVIO (Novartis) Long-Acting Cholesterol-Lowering Drugs Introduction

11.1.4 LEQVIO (Novartis) Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

11.1.5 LEQVIO (Novartis) Recent Development

11.2 Verve Therapeutics

11.2.1 Verve Therapeutics Company Details

11.2.2 Verve Therapeutics Business Overview

11.2.3 Verve Therapeutics Long-Acting Cholesterol-Lowering Drugs Introduction

11.2.4 Verve Therapeutics Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

11.2.5 Verve Therapeutics Recent Development

11.3 Jiangsu Hengrui Pharmaceuticals

11.3.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.3.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.3.3 Jiangsu Hengrui Pharmaceuticals Long-Acting Cholesterol-Lowering Drugs Introduction

11.3.4 Jiangsu Hengrui Pharmaceuticals Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

11.3.5 Jiangsu Hengrui Pharmaceuticals Recent Development

11.4 Amgen

11.4.1 Amgen Company Details

11.4.2 Amgen Business Overview

11.4.3 Amgen Long-Acting Cholesterol-Lowering Drugs Introduction

11.4.4 Amgen Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

11.4.5 Amgen Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Long-Acting Cholesterol-Lowering Drugs Introduction

11.5.4 Sanofi Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

11.5.5 Sanofi Recent Development

11.6 Innovent

11.6.1 Innovent Company Details

11.6.2 Innovent Business Overview

11.6.3 Innovent Long-Acting Cholesterol-Lowering Drugs Introduction

11.6.4 Innovent Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

11.6.5 Innovent Recent Development

11.7 Akesobio

11.7.1 Akesobio Company Details

11.7.2 Akesobio Business Overview

11.7.3 Akesobio Long-Acting Cholesterol-Lowering Drugs Introduction

11.7.4 Akesobio Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

11.7.5 Akesobio Recent Development

11.8 Junshi Biosciences

11.8.1 Junshi Biosciences Company Details

11.8.2 Junshi Biosciences Business Overview

11.8.3 Junshi Biosciences Long-Acting Cholesterol-Lowering Drugs Introduction

11.8.4 Junshi Biosciences Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

11.8.5 Junshi Biosciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Verve Therapeutics

Jiangsu Hengrui Pharmaceuticals

List of Tables

Table 1. Global Long-Acting Cholesterol-Lowering Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Long-Acting Cholesterol-Lowering Drugs

Table 3. Key Players of Ultra-Long-Acting Cholesterol-Lowering Drugs

Table 4. Global Long-Acting Cholesterol-Lowering Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Long-Acting Cholesterol-Lowering Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Long-Acting Cholesterol-Lowering Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Long-Acting Cholesterol-Lowering Drugs Market Share by Region (2020-2025)

Table 8. Global Long-Acting Cholesterol-Lowering Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Long-Acting Cholesterol-Lowering Drugs Market Share by Region (2026-2031)

Table 10. Long-Acting Cholesterol-Lowering Drugs Market Trends

Table 11. Long-Acting Cholesterol-Lowering Drugs Market Drivers

Table 12. Long-Acting Cholesterol-Lowering Drugs Market Challenges

Table 13. Long-Acting Cholesterol-Lowering Drugs Market Restraints

Table 14. Global Long-Acting Cholesterol-Lowering Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Long-Acting Cholesterol-Lowering Drugs Market Share by Players (2020-2025)

Table 16. Global Top Long-Acting Cholesterol-Lowering Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Cholesterol-Lowering Drugs as of 2024)

Table 17. Ranking of Global Top Long-Acting Cholesterol-Lowering Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Long-Acting Cholesterol-Lowering Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Long-Acting Cholesterol-Lowering Drugs, Headquarters and Area Served

Table 20. Global Key Players of Long-Acting Cholesterol-Lowering Drugs, Product and Application

Table 21. Global Key Players of Long-Acting Cholesterol-Lowering Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Long-Acting Cholesterol-Lowering Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Long-Acting Cholesterol-Lowering Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Long-Acting Cholesterol-Lowering Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Long-Acting Cholesterol-Lowering Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Long-Acting Cholesterol-Lowering Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Long-Acting Cholesterol-Lowering Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Long-Acting Cholesterol-Lowering Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Long-Acting Cholesterol-Lowering Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Long-Acting Cholesterol-Lowering Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Long-Acting Cholesterol-Lowering Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Long-Acting Cholesterol-Lowering Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. LEQVIO (Novartis) Company Details

Table 47. LEQVIO (Novartis) Business Overview

Table 48. LEQVIO (Novartis) Long-Acting Cholesterol-Lowering Drugs Product

Table 49. LEQVIO (Novartis) Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 50. LEQVIO (Novartis) Recent Development

Table 51. Verve Therapeutics Company Details

Table 52. Verve Therapeutics Business Overview

Table 53. Verve Therapeutics Long-Acting Cholesterol-Lowering Drugs Product

Table 54. Verve Therapeutics Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 55. Verve Therapeutics Recent Development

Table 56. Jiangsu Hengrui Pharmaceuticals Company Details

Table 57. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 58. Jiangsu Hengrui Pharmaceuticals Long-Acting Cholesterol-Lowering Drugs Product

Table 59. Jiangsu Hengrui Pharmaceuticals Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 60. Jiangsu Hengrui Pharmaceuticals Recent Development

Table 61. Amgen Company Details

Table 62. Amgen Business Overview

Table 63. Amgen Long-Acting Cholesterol-Lowering Drugs Product

Table 64. Amgen Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 65. Amgen Recent Development

Table 66. Sanofi Company Details

Table 67. Sanofi Business Overview

Table 68. Sanofi Long-Acting Cholesterol-Lowering Drugs Product

Table 69. Sanofi Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. Innovent Company Details

Table 72. Innovent Business Overview

Table 73. Innovent Long-Acting Cholesterol-Lowering Drugs Product

Table 74. Innovent Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 75. Innovent Recent Development

Table 76. Akesobio Company Details

Table 77. Akesobio Business Overview

Table 78. Akesobio Long-Acting Cholesterol-Lowering Drugs Product

Table 79. Akesobio Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 80. Akesobio Recent Development

Table 81. Junshi Biosciences Company Details

Table 82. Junshi Biosciences Business Overview

Table 83. Junshi Biosciences Long-Acting Cholesterol-Lowering Drugs Product

Table 84. Junshi Biosciences Revenue in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025) & (US$ Million)

Table 85. Junshi Biosciences Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Long-Acting Cholesterol-Lowering Drugs Picture

Figure 2. Global Long-Acting Cholesterol-Lowering Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Long-Acting Cholesterol-Lowering Drugs Market Share by Type: 2024 VS 2031

Figure 4. Long-Acting Cholesterol-Lowering Drugs Features

Figure 5. Ultra-Long-Acting Cholesterol-Lowering Drugs Features

Figure 6. Global Long-Acting Cholesterol-Lowering Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Long-Acting Cholesterol-Lowering Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hyperlipidemia Case Studies

Figure 9. Hypertension Case Studies

Figure 10. Diabetes Case Studies

Figure 11. Others Case Studies

Figure 12. Long-Acting Cholesterol-Lowering Drugs Report Years Considered

Figure 13. Global Long-Acting Cholesterol-Lowering Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Long-Acting Cholesterol-Lowering Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Long-Acting Cholesterol-Lowering Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Long-Acting Cholesterol-Lowering Drugs Market Share by Players in 2024

Figure 17. Global Long-Acting Cholesterol-Lowering Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Long-Acting Cholesterol-Lowering Drugs Revenue in 2024

Figure 19. North America Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Long-Acting Cholesterol-Lowering Drugs Market Share by Country (2020-2031)

Figure 21. United States Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Long-Acting Cholesterol-Lowering Drugs Market Share by Country (2020-2031)

Figure 25. Germany Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Long-Acting Cholesterol-Lowering Drugs Market Share by Region (2020-2031)

Figure 33. China Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Long-Acting Cholesterol-Lowering Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Long-Acting Cholesterol-Lowering Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Long-Acting Cholesterol-Lowering Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. LEQVIO (Novartis) Revenue Growth Rate in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

Figure 49. Verve Therapeutics Revenue Growth Rate in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

Figure 50. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

Figure 51. Amgen Revenue Growth Rate in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

Figure 52. Sanofi Revenue Growth Rate in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

Figure 53. Innovent Revenue Growth Rate in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

Figure 54. Akesobio Revenue Growth Rate in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

Figure 55. Junshi Biosciences Revenue Growth Rate in Long-Acting Cholesterol-Lowering Drugs Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Statins Market Research Report 2024

Global PCSK9 Cholesterol Lowering Drugs Market Research Report 2025

Antihyperlipidemic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cholesterol Absorption Inhibitors Market Research Report 2024

Global Nonstatin Cholesterol Medications Market Research Report 2024

Global Long acting Weight Loss Drugs Market Research Report 2024

Global Cholesterol Lowering Biologic Drugs Market Research Report 2024

Global Blood Lipid Regulating Drugs Market Research Report 2024

Global Statin Market Research Report 2024

Global PCSK9 Targeted Drugs Market Research Report 2024

Global Ezetimibe Tablets Market Research Report 2024

Lipid Lowering Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti hyperlipidemic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cholesterol Lowering Supplements Market Research Report 2024

Global PCSK9 Antagonists Market Research Report 2024

Chemical Lipid Lowering Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cholesterol Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long acting Anti HIV Drugs Market Research Report 2024

Global Long Acting Contraceptive Pills Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions